
CAS 1252927-45-9
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
4 Produkte.
Pazopanib 4-chloropyrimidine (N-(4-Chloropyrimidin-2-yl)-N,2,3-trimethyl-2H-indazol-6-amine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormel:C14H14ClN5Farbe und Form:Off-White SolidMolekulargewicht:287.09377N-(4-Chloro-2-pyrimidinyl)-N,2,3-trimethyl-2H-indazol-6-amine
CAS:Kontrolliertes Produkt<p>Applications N-(4-Chloro-2-pyrimidinyl)-N,2,3-trimethyl-2H-indazol-6-amine is an intermediate in the synthesis of 5-((2-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-4-yl)amino)-2-methylbenzenesulfonamide Hydrochloride (D474433) which is an impurity of Pazopanib (P210925), which is an oral angiogenesis inhibitor targeting VEGFR and PDGFR.<br>References Olaussen, K., et al.: Oncogen., 28, 4249 (2009), Sleijfer, S., et al.: J. Clin. Oncol., 27, 3126 (2009), Chan, A., et al.: Drugs, 69, 167 (2009),<br></p>Formel:C14H14ClN5Farbe und Form:NeatMolekulargewicht:287.75N-(4-Chloro-2-pyrimidinyl)-N,2,3-trimethyl-2H-indazol-6-amine
CAS:<p>Please enquire for more information about N-(4-Chloro-2-pyrimidinyl)-N,2,3-trimethyl-2H-indazol-6-amine including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formel:C14H14ClN5Reinheit:Min. 95%Molekulargewicht:287.75 g/molPazopanib Related Compound B
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormel:C14H14ClN5Farbe und Form:Off-White SolidMolekulargewicht:287.09377



